Core Viewpoint - The stock of AVIC Chengfei has shown a modest increase of 2.00% as of January 5, 2023, with significant trading activity and a total market capitalization of 215.32 billion yuan [1]. Group 1: Stock Performance - As of January 5, 2023, AVIC Chengfei's stock price is 80.58 yuan per share, with a trading volume of 7.76 billion yuan and a turnover rate of 1.66% [1]. - Year-to-date, the stock has increased by 2.00%, with a 5-day increase of 2.45%, a 20-day increase of 3.83%, but a 60-day decrease of 10.70% [1]. Group 2: Financial Performance - For the period from January to September 2025, AVIC Chengfei reported a revenue of 48.29 billion yuan, reflecting a year-on-year growth of 3962.86%, and a net profit attributable to shareholders of 2.17 billion yuan, up by 2001.33% [2]. Group 3: Shareholder Information - As of December 31, 2025, the number of shareholders for AVIC Chengfei is 73,000, an increase of 0.75% from the previous period, with an average of 8,022 circulating shares per shareholder, a decrease of 0.75% [2]. - The top ten circulating shareholders include notable ETFs, with the largest being the Fortune CSI Military Industry Leader ETF, holding 6.63 million shares, an increase of 968,800 shares from the previous period [3].

1月5日，航发控制盘中下跌2.02%，截至10:59，报20.88元/股，成交4.71亿元，换手率1.69%，总市值 274.61亿元。 资金流向方面，主力资金净流出1384.54万元，特大单买入2816.23万元，占比5.98%，卖出3488.97万 元，占比7.41%；大单买入1.17亿元，占比24.86%，卖出1.24亿元，占比26.37%。 截至12月19日，航发控制股东户数7.23万，较上期增加6.02%；人均流通股18182股，较上期减少 5.68%。2025年1月-9月，航发控制实现营业收入39.68亿元，同比减少5.75%；归母净利润4.01亿元，同 比减少36.25%。 分红方面，航发控制A股上市后累计派现9.03亿元。近三年，累计派现5.14亿元。 机构持仓方面，截止2025年9月30日，航发控制十大流通股东中，华夏军工安全混合A（002251）位居 第五大流通股东，持股2613.91万股，相比上期增加1432.77万股。富国中证军工龙头ETF（512710）位 居第七大流通股东，持股1783.82万股，相比上期增加267.73万股。南方中证500ETF（510500）位居第 十大流通股东 ...

Core Viewpoint - The stock of Shengyang Technology has experienced a decline of 2.06% as of January 5, with a market capitalization of 5.926 billion yuan, reflecting mixed trading activity and a notable increase in revenue and profit year-on-year [1][2]. Group 1: Stock Performance - As of January 5, Shengyang Technology's stock price is 14.28 yuan per share, with a trading volume of 287 million yuan and a turnover rate of 4.76% [1]. - Year-to-date, the stock has decreased by 2.06%, with a slight decline of 0.35% over the last five trading days, but has increased by 20.30% over the last 20 days and 26.60% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Shengyang Technology reported a revenue of 644 million yuan, representing a year-on-year growth of 13.39%, and a net profit attributable to shareholders of 7.1347 million yuan, up by 6.16% [2]. - Cumulatively, the company has distributed 55.9729 million yuan in dividends since its A-share listing, with 4.8876 million yuan distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Shengyang Technology has increased to 24,300, marking an 8.30% rise, while the average circulating shares per person have decreased by 7.66% to 17,090 shares [2]. - Notably, the fund "Huaxia Industry Prosperity Mixed A" has exited the list of the top ten circulating shareholders [3]. Group 4: Business Overview - Shengyang Technology, established on June 10, 2003, and listed on April 23, 2015, is located in Shaoxing City, Zhejiang Province, and specializes in the research, manufacturing, and sales of various RF cables and related products [1]. - The company's main business revenue composition includes RF cable products (35.83%), display devices (34.92%), high-frequency heads and related accessories (14.39%), others (9.55%), and 5G communication base station services (5.31%) [1].

Core Viewpoint - The stock of Xinyu Guoke has experienced a decline of 2.03% as of January 5, with a current price of 34.80 CNY per share and a total market capitalization of 9.631 billion CNY [1]. Group 1: Stock Performance - As of January 5, Xinyu Guoke's stock has decreased by 2.03% year-to-date, with no change over the last five trading days, a 9.47% increase over the last 20 days, and a 10.93% increase over the last 60 days [1]. - The trading volume on January 5 was 234 million CNY, with a turnover rate of 2.39% [1]. Group 2: Financial Performance - For the period from January to September 2025, Xinyu Guoke reported a revenue of 262 million CNY, representing a year-on-year decrease of 17.89%, and a net profit attributable to shareholders of 48.19 million CNY, down 26.72% year-on-year [2]. Group 3: Shareholder Information - As of December 20, Xinyu Guoke had 30,600 shareholders, with an average of 9,039 circulating shares per shareholder, showing no change from the previous period [2]. - The company has distributed a total of 257 million CNY in dividends since its A-share listing, with 116 million CNY distributed over the last three years [3]. - As of September 30, 2025, Hong Kong Central Clearing Limited was the sixth largest circulating shareholder, holding 1.9995 million shares, an increase of 1.6246 million shares from the previous period [3]. Group 4: Company Overview - Xinyu Guoke, established on May 5, 2008, and listed on November 10, 2017, is located in Xianjiao Town, Xinyu City, Jiangxi Province. The company specializes in the research, production, and sales of explosives and related products, focusing on both military and civilian applications [1]. - The revenue composition of Xinyu Guoke includes 69.59% from military products, 29.20% from civilian products, and 1.21% from other sources [1]. - The company operates within the defense and military industry, specifically in aerospace equipment, and is involved in concepts such as large aircraft, military-civilian integration, and drones [1].

Core Viewpoint - Jiukang Bio's stock price has shown a slight increase of 2.07% this year, but has experienced a decline over the past five and twenty trading days, indicating potential volatility in its stock performance [1]. Group 1: Stock Performance - As of January 5, Jiukang Bio's stock price reached 13.34 yuan per share, with a market capitalization of 7.821 billion yuan [1]. - The stock has seen a 2.07% increase year-to-date, a 0.60% decrease over the last five trading days, a 1.84% decrease over the last twenty days, and a 0.75% increase over the last sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Jiukang Bio reported a revenue of 1.012 billion yuan, representing an 18.24% year-on-year decrease, and a net profit attributable to shareholders of 272 million yuan, down 27.03% year-on-year [2]. - Cumulatively, since its A-share listing, Jiukang Bio has distributed a total of 1.33 billion yuan in dividends, with 701 million yuan distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, Jiukang Bio had 18,100 shareholders, a decrease of 2.48% from the previous period, with an average of 23,502 circulating shares per shareholder, an increase of 2.54% [2]. - Among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF held 8.3446 million shares, a decrease of 1.4085 million shares compared to the previous period [3]. Group 4: Business Overview - Jiukang Bio, established on March 29, 2001, and listed on October 30, 2014, specializes in the research, production, and sales of biochemical diagnostics, blood coagulation testing, blood type testing, and tumor pathology testing [1]. - The company's main revenue sources include in vitro diagnostic reagents (95.09%), in vitro testing instruments (3.06%), other business income (0.96%), inspection services (0.53%), and instrument leasing income (0.36%) [1].

Core Viewpoint - Huanxin Building Materials has shown a positive stock performance with a year-to-date increase of 2.12% and significant growth over various trading periods, indicating strong market interest and potential for future growth [1][2]. Group 1: Stock Performance - As of January 5, Huanxin Building Materials' stock price reached 25.06 CNY per share, with a trading volume of 98.41 million CNY and a turnover rate of 0.30%, resulting in a total market capitalization of 52.1 billion CNY [1]. - The stock has increased by 2.92% over the last five trading days, 11.83% over the last twenty days, and 38.91% over the last sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Huanxin Building Materials reported a revenue of 25.033 billion CNY, reflecting a year-on-year growth of 1.27%, while the net profit attributable to shareholders was 2.004 billion CNY, marking a significant increase of 76.01% [2]. - Cumulatively, the company has distributed 14.3 billion CNY in dividends since its A-share listing, with 3.833 billion CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Huanxin Building Materials was 42,600, a decrease of 6.81% from the previous period [2]. - The largest circulating shareholder, Hong Kong Central Clearing Limited, holds 62.0928 million shares, an increase of 5.1895 million shares compared to the previous period [3].

Core Viewpoint - Yangjie Technology's stock has shown a positive trend with a 2.00% increase on January 5, 2023, and a total market capitalization of 37.687 billion yuan, indicating strong investor interest and potential growth in the semiconductor sector [1]. Group 1: Stock Performance - As of January 5, 2023, Yangjie Technology's stock price reached 69.36 yuan per share, with a trading volume of 4.09 billion yuan and a turnover rate of 1.10% [1]. - Year-to-date, the stock price has increased by 2.00%, with a 3.85% rise over the last five trading days and a 7.48% increase over the last twenty days, while it has decreased by 1.10% over the last sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Yangjie Technology reported a revenue of 5.348 billion yuan, reflecting a year-on-year growth of 20.89%, and a net profit attributable to shareholders of 974 million yuan, which is a 45.51% increase compared to the previous year [2]. - The company has distributed a total of 1.717 billion yuan in dividends since its A-share listing, with 1.180 billion yuan distributed over the last three years [3]. Group 3: Shareholder Information - As of December 31, 2025, the number of shareholders for Yangjie Technology reached 60,000, an increase of 9.09% from the previous period, while the average number of tradable shares per shareholder decreased by 8.33% to 9,035 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 8.312 million shares, an increase of 390,600 shares, while E Fund's ChiNext ETF and Southern CSI 500 ETF have seen reductions in their holdings [3].

Core Viewpoint - Wante Bio's stock price has shown a slight increase of 2.00% recently, but the company has experienced a significant decline in revenue and profit year-on-year, indicating potential challenges ahead [1][2]. Group 1: Stock Performance - As of January 5, Wante Bio's stock price reached 45.84 CNY per share, with a market capitalization of 57.96 billion CNY [1]. - The stock has seen a 2.00% increase year-to-date, but has declined by 2.11% over the last five trading days, 1.46% over the last twenty days, and 21.12% over the last sixty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Wante Bio reported a revenue of 1.498 billion CNY, a decrease of 23.09% year-on-year [2]. - The company recorded a net profit of -173 million CNY, representing a significant decline of 165.04% compared to the previous year [2]. Group 3: Shareholder Information - As of September 30, 2025, Wante Bio had 42,000 shareholders, an increase of 9.41% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 8.60% to 30,124 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which reduced its holdings by 9.8553 million shares, and new shareholder招商国证生物医药指数A, holding 4.9609 million shares [3].

Core Viewpoint - The stock price of Daodaoquan has increased by 2.09% this year, with fluctuations in recent trading days indicating mixed performance in the short term [2]. Group 1: Stock Performance - As of January 5, Daodaoquan's stock price is reported at 10.77 yuan per share, with a market capitalization of 3.705 billion yuan [1]. - The stock has seen a net inflow of 552,200 yuan from main funds, with large orders accounting for 16.64% of purchases and 14.07% of sales [1]. - Over the past five trading days, the stock has decreased by 1.10%, while it has increased by 1.60% over the past 20 days [2]. Group 2: Company Overview - Daodaoquan Grain and Oil Co., Ltd. is located in Changsha, Hunan Province, and was established on July 28, 1999, with its stock listed on March 10, 2017 [2]. - The company's main business involves the research, production, and sales of edible vegetable oil products, with revenue composition as follows: packaged oil 62.71%, meal products 22.45%, bulk oil 13.67%, and others 1.17% [2]. - The company belongs to the agricultural and forestry industry, specifically in the agricultural product processing sector, focusing on grain and oil processing [2]. Group 3: Financial Performance - For the period from January to September 2025, Daodaoquan achieved a revenue of 4.397 billion yuan, representing a year-on-year growth of 4.62% [2]. - The net profit attributable to the parent company reached 216 million yuan, showing a significant year-on-year increase of 93.69% [2]. - Since its A-share listing, Daodaoquan has distributed a total of 485 million yuan in dividends, with 234 million yuan distributed over the past three years [3].

Core Viewpoint - The stock of Shenghe Resources has shown a modest increase of 2.04% as of January 5, 2023, with significant trading activity and a total market capitalization of 38.51 billion yuan [1]. Group 1: Stock Performance - As of January 5, 2023, Shenghe Resources' stock price is 21.97 yuan per share, with a trading volume of 447 million yuan and a turnover rate of 1.17% [1]. - Year-to-date, the stock has increased by 2.04%, with a 5-day increase of 2.28%, a 20-day increase of 6.96%, and a 60-day decrease of 12.71% [1]. Group 2: Financial Performance - For the period from January to September 2025, Shenghe Resources reported a revenue of 10.456 billion yuan, representing a year-on-year growth of 26.87%, and a net profit attributable to shareholders of 788 million yuan, reflecting a significant year-on-year increase of 748.07% [2]. Group 3: Shareholder Information - As of December 20, 2025, the number of shareholders of Shenghe Resources is 210,400, a decrease of 6.11% from the previous period, while the average number of circulating shares per person has increased by 6.50% to 8,329 shares [2]. - The company has distributed a total of 1.039 billion yuan in dividends since its A-share listing, with 561 million yuan distributed over the past three years [3]. - As of September 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable changes in their holdings [3].